Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2018.02.79
Abstract: The discovery and clinical application of immune-checkpoint inhibitors has dramatically improved the treatments, outcomes and therapeutic concepts in multiple tumor settings. This breakthrough was mainly based on monoclonal antibodies blocking the inhibitory molecule CTLA-4 and…
read more here.
Keywords:
next generation;
immune checkpoints;
checkpoints cancer;
generation immune ... See more keywords